Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

Leukemia

Volumn 13, Issue 1, 1999, Pages 110-118

  Pongers Willemse, M J ^a   Seriu, T ^b   Stolz, F ^c   D'Aniello, E ^d   Gameiro, P ^e   Pisa, P ^f   Gonzalez, M ^g   Bartram, C R ^b   Panzer Grumayer E R ^c   Biondi, A ^d   San Miguel, J F ^g   Van Dongen, J J M ^a,h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^d UNIVERSITY OF MILAN   (Italy)

^e INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^h ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

BIOMED 1; Immunoglobulin genes; Junctional region; MRD; PCR primers; T cell receptor genes; TAL1 deletion

Indexed keywords

PRIMER DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; DELETION MUTANT; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

EID: 0032919213     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401245     Document Type: Article

References (37)

1. Biondi A, Yokota S, Hansen-Hagge TE, Rossi V, Giudici G, Maglia O, Basso G, Tell C, Masera G, Bartram CR. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 1992; 6: 282-288.
2. Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 1995; 9: 615-623.
3. Van Dongen JJM, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral E, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, Van Wering ER, Ludwig W-D, Basso G, de Bruijn MAC, Cazzaniga G, Hettinger K, Van der Does-van den Berg A, Hop WCJ, Riehm H, Bartram CR. Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia. A prospective study of the International BFM Study Group. Lancet 1998 (in press).
4. Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui CH, Campana D. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998; 351: 550-554.
5. Van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6: 47-59.
6. Van Dongen JJM, Szczepanski T, De Bruijn MAC, Van den Beemd MWM, De Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJM, Van Gastel-Mol EJ, Groeneveld K, Hooijkaas H. Detection of minimal residual disease in acute leukemia patients. Cytokin Mol Ther 1996; 2: 121-133.
7. San Miguel JF, Parreira A, Wörmann B, Bartram CA, Janossy G, Van Dongen JJM. Investigation of minimal residual disease in acute non-lymphoblastic leukemia: international standardization and clinical evaluation. In: Baert AE, Baig SS, Bardoux C, Fracchia GN, Hallen M, Le Dour O, Razguin MC, Thevenin V, Vanvossel A, Vidal M (eds). European Union Biomedical and Health Research: the BIOMED-1 Programme. IOS Press: Amsterdam, 1995, pp 372-373.
8. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
9. Seriu T, Hansen-Hagge TE, Erz DH, Bartram CR. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions. Leukemia 1995; 9: 316-320.
10. Beishuizen A, Hählen K, Hagemeijer A, Verhoeven MA, Hooijkaas H, Adriaansen HJ, Wolvers-Tettero ILM, Van Wering ER, Van Dongen JJM. Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia 1991; 5: 657-667.
11. Ghali DW, Panzer S, Fischer S, Argyriou-Tirita A, Haas OA, Kovar H, Gadner H, Panzer-Grumayer ER. Heterogeneity of the T cell receptor delta gene indicating subclone formation in acute precursor B cell leukemias. Blood 1995; 85: 2795-2801.
12. Steenbergen EJ, Verhagen OJ, Van den Berg H, Van Leeuwen EF, Behrendt H, Slater RR, Von dem Borne AE, Van der Schoot CE. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia. Leukemia 1997; 11: 1258-1265.
13. Wasserman R, Yamada M, Ito Y, Finger ER, Reichard BA, Shane S, Lange B, Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223-228.
14. Steenbergen EJ, Verhagen OJ, Van Leeuwen EF, Von dem Borne AE, Van der Schoot CE. Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia. Blood 1993; 82: 581-589.
15. Beishuizen A, Verhoeven MA, Van Wering ER, Hählen K, Hooijkaas H, Van Dongen JJM. Analysis of Ig and T cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238-2247.
16. Steward CG, Goulden NJ, Katz F, Baines D, Martin PG, Langlands K, Potter MN, Chessells JM, Oakhill A. A polymerase chain reaction study of the stability of Ig heavy-chain and T cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
17. Taylor JJ, Rowe D, Kylefjord H, Chessells J, Katz F, Proctor SJ, Middleton PG. Characterisation of non-concordance in the T cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia. Leukemia 1994; 8: 60-66.
18. Baruchel A, Cayuela JM, Maclntyre E, Berger R, Sigaux F. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection. Br J Haematol 1995; 90: 85-93.
19. Choi Y, Greenberg SJ, Du TL, Ward PM, Overturf PM, Brecher ML, Ballow M. Clonal evolution in B-lineage acute lymphoblastic leukemia by contemporaneous VH-VH gene replacements and VH-DJH gene rearrangements. Blood 1996; 87: 2506-2512.
20. Felix CA, Poplack DG. Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T cell receptor gene patterns. Leukemia 1991; 5: 1015-1025.
21. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991; 198: 93-174.
22. Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoeven M-AJ, Van Wering ER, Van Dongen JJM. Southern blot patterns, frequencies and junctional diversity of T cell receptor d gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063-3074.
23. Beishuizen A, Verhoeven MA, Mol EJ, Van Dongen JJM. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. Leukemia 1994; 8: 2228-2236.
24. Beishuizen A, De Bruijn MAC, Pongers-Willemse MJ, Verhoeven M-AJ, Van Wering ER, Hählen K, Breit TM, De Bruin-Versteeg S, Hooijkaas H, Van Dongen JJM. Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 1997; 11: 2200-2207.
25. Breit TM, Mol EJ, Wolvers-Tettero ILM, Ludwig WD, Van Wering ER, Van Dongen JJM. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med 1993; 177: 965-977.
26. Breit TM, Beishuizen A, Ludwig WD, Mol EJ, Adriaansen HJ, Van Wering ER, Van Dongen JJM. tal-1 deletions in T cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia 1993; 7: 2004-2011.
27. Van Dongen JJM, Wolvers-Tettero ILM. Analysis of immunoglobulin and T cell receptor genes. Part I: basic and technical aspects. Clin Chim Acta 1991; 198: 1-91.
28. Quertermous T, Strauss WM, Van Dongen JJM, Seidman JG. Human T cell gamma chain joining regions and T cell development. J Immunol 1987; 138: 2687-2690.
29. Biondi A, Francia di Celle P, Rossi V, Casorati G, Matullo G, Giudici G, Foa R, Migone N. High prevalence of T cell receptor V delta 2-(D)-D delta 3 or D delta 1/2-D delta 3 rearrangements in B-precursor acute lymphoblastic leukemias. Blood 1990; 75: 1834-1840.
30. Seriu T, Erz D, Stark Y, Bartram CR. T cell receptor Ddelta2D-delta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 759-761.
31. Breit TM, Wolvers-Tettero ILM, Hählen K, Van Wering ER, Van Dongen JJM. Extensive junctional diversity of gd T cell receptors expressed by T cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease. Leukemia 1991; 5: 1076-1086.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual. 2nd edn, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989.
33. Drexler HG, MacLeod RA, Borkhardt A, Janssen JW. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines. Leukemia 1995; 9: 480-500.
34. Langerak AW, Szczepanski T, Van der Burg M, Wolvers-Tettero ILM, Van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192-2199.
35. Szczepański T, Langerak AW, Wolvers-Tettero ILM, Ossenkoppele GJ, Verhoef G, Stul M, Petersen EJ, De Bruijn MAC, Van't Veer MB, Van Dongen JJM. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998; 12: 1081-1088.
36. Steenbergen EJ, Verhagen OJ, Van Leeuwen EF, Van den Berg H, Von dem Borne AE, Van der School CE. Frequent ongoing T cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease. Blood 1995; 86: 692-702.
37. Van Dongen JJM, Comans-Bitter WM, Wolvers-Tettero ILM, Borst J. Development of human T lymphocytes and their thymus dependency. Thymus 1990; 16: 207-234.